217 related articles for article (PubMed ID: 31296577)
1. Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells
Ando M; Ando J; Yamazaki S; Ishii M; Sakiyama Y; Harada S; Honda T; Yamaguchi T; Nojima M; Ohshima K; Nakauchi H; Komatsu N
Haematologica; 2020 Mar; 105(3):796-807. PubMed ID: 31296577
[TBL] [Abstract][Full Text] [Related]
2. [iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas].
Ando M; Nakauchi H; Komatsu N
Rinsho Ketsueki; 2018; 59(7):932-938. PubMed ID: 30078805
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
4. [Induced pluripotent stem cell-derived rejuvenated cytotoxic T lymphocyte therapy for Epstein-Barr virus-associated lymphomas: application to clinical practice].
Ando M
Rinsho Ketsueki; 2022; 63(9):1310-1315. PubMed ID: 36198557
[TBL] [Abstract][Full Text] [Related]
5. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
6. A Rare Case of Aggressive Disseminated Nasal-Type Epstein-Barr Virus-Positive Extranodal Natural Killer/T-Cell Lymphoma with Bone Marrow Involvement.
Yee AC; Karim FW; Giashuddin SM; Grutman G
Am J Case Rep; 2023 Jun; 24():e939286. PubMed ID: 37384825
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
8. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
11. Review on natural killer/T-cell lymphoma.
He X; Gao Y; Li Z; Huang H
Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
[TBL] [Abstract][Full Text] [Related]
12. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
Kwong YL; Chan TSY; Tan D; Kim SJ; Poon LM; Mow B; Khong PL; Loong F; Au-Yeung R; Iqbal J; Phipps C; Tse E
Blood; 2017 Apr; 129(17):2437-2442. PubMed ID: 28188133
[TBL] [Abstract][Full Text] [Related]
13. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Lin N; Ku W; Song Y; Zhu J; Lu Z
Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
[TBL] [Abstract][Full Text] [Related]
15. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
[TBL] [Abstract][Full Text] [Related]
16. Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.
Tse E; Fox CP; Glover A; Yoon SE; Kim WS; Kwong YL
Semin Hematol; 2022 Oct; 59(4):198-209. PubMed ID: 36805888
[TBL] [Abstract][Full Text] [Related]
17. [The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma].
Yao N; Cui X; Wang J
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):106-10. PubMed ID: 25907839
[TBL] [Abstract][Full Text] [Related]
18. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
[TBL] [Abstract][Full Text] [Related]
19. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
[TBL] [Abstract][Full Text] [Related]
20. Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma.
Harada S; Ando M; Ando J; Ishii M; Yamaguchi T; Yamazaki S; Toyota T; Ohara K; Ohtaka M; Nakanishi M; Shin C; Ota Y; Nakashima K; Ohshima K; Imai C; Nakazawa Y; Nakauchi H; Komatsu N
Mol Ther; 2022 Feb; 30(2):534-549. PubMed ID: 34628050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
